The new stem cell biology.

Recent studies have indicated that bone marrow stem cells are capable of generating muscle, cardiac, hepatic, renal, and bone cells. Purified hematopoietic stem cells have generated cardiac and hepatic cells and reversed disease manifestations in these tissues. Hematopoietic stem cells also alter phenotype with cell cycle transit or circadian phase. During a cytokine stimulated cell cycle transit, reversible alterations of differentiation and engraftment occur. Primitive hematopoietic stem cells express a wide variety of adhesion and cytokine receptors and respond quickly with migration and podia extensions on exposure to cytokines. These data suggest an "Open Chromatin" model of stem cell regulation in which there is a fluctuating continuum in the stem cell/progenitor cell compartments, rather than a hierarchical relationship. These observations, along with progress in using low dose treatments and tolerization approaches, suggest many new therapeutic strategies involving stem cells and the creation of a new medical specialty; stemology.

[1]  M. Ogawa,et al.  Bone marrow origin of hematopoietic progenitors and stem cells in murine muscle. , 2001, Blood.

[2]  Neil D. Theise,et al.  Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.

[3]  S. Nilsson,et al.  Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. , 2001, Blood.

[4]  P. Quesenberry,et al.  The fleet feet of haematopoietic stem cells: rapid motility, interaction and proteopodia , 2001, British journal of haematology.

[5]  P. Quesenberry,et al.  Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice. , 2001, Blood.

[6]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[7]  Xin Wang,et al.  Purified hematopoietic stem cells can differentiate into hepatocytes in vivo , 2000, Nature Medicine.

[8]  P. Quesenberry,et al.  Cytokine treatment of hematopoietic stem/progenitor cells induces a homing defect in nonmyeloablated hosts , 2000 .

[9]  J. Wuu,et al.  Definitive evidence for the influence of circadian rhythm on bone marrow (Bm) Stem cell engraftability , 2000 .

[10]  M. Busslinger,et al.  Fidelity and infidelity in commitment to B-lymphocyte lineage development. , 2000, Immunological reviews.

[11]  T. Papayannopoulou,et al.  Hemopoietic lineage commitment decisions: in vivo evidence from a transgenic mouse model harboring μLCR-βpro-LacZ as a transgene , 2000 .

[12]  Sunil Badve,et al.  Derivation of hepatocytes from bone marrow cells in mice after radiation‐induced myeloablation , 2000, Hepatology.

[13]  M. Goodell,et al.  Hematopoietic potential of stem cells isolated from murine skeletal muscle. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  B. Palsson,et al.  Key adhesion molecules are present on long podia extended by hematopoietic cells. , 1999, Cytometry.

[15]  R. Mulligan,et al.  Dystrophin expression in the mdx mouse restored by stem cell transplantation , 1999, Nature.

[16]  T. Enver,et al.  Functional and molecular analysis of hematopoietic progenitors derived from the aorta-gonad-mesonephros region of the mouse embryo. , 1999, Blood.

[17]  P. Quesenberry,et al.  Effects of cytokines on stem cell engraftment depends on time of evaluation post-marrow-infusion. , 1999, International journal of hematology.

[18]  W. Mars,et al.  Bone marrow as a potential source of hepatic oval cells. , 1999, Science.

[19]  I. Weissman,et al.  In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Nilsson,et al.  Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. , 1999, Experimental hematology.

[21]  B. Frenkel,et al.  Cells Capable of Bone Production Engraft from Whole Bone Marrow Transplants in Nonablated Mice , 1999, The Journal of experimental medicine.

[22]  A. Vescovi,et al.  Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. , 1999, Science.

[23]  B. Palsson,et al.  Two new pseudopod morphologies displayed by the human hematopoietic KG1a progenitor cell line and by primary human CD34(+) cells. , 1998, Blood.

[24]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[25]  J. Wuu,et al.  The Fluctuating Phenotype of the Lymphohematopoietic Stem Cell with Cell Cycle Transit , 1998, The Journal of experimental medicine.

[26]  J. Wuu,et al.  Lymphohematopoietic engraftment in minimally myeloablated hosts. , 1998, Blood.

[27]  P. Quesenberry,et al.  Repetitive bone marrow transplantation in nonmyeloablated recipients. , 1998, Experimental hematology.

[28]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[29]  S. Nilsson,et al.  Synchronized cell-cycle induction of engrafting long-term repopulating stem cells. , 1997, Blood.

[30]  S. Nilsson,et al.  Potential and distribution of transplanted hematopoietic stem cells in a nonablated mouse model. , 1997, Blood.

[31]  B. Williams,et al.  Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. , 1997, Experimental hematology.

[32]  H. Ramshaw,et al.  Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment. , 1997, Experimental hematology.

[33]  S. Nilsson,et al.  In situ detection of individual transplanted bone marrow cells using FISH on sections of paraffin-embedded whole murine femurs. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  H. Ramshaw,et al.  High levels of engraftment with a single infusion of bone marrow cells into normal unprepared mice. , 1995, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[35]  A. Caplan,et al.  Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidine , 1995, Muscle & nerve.

[36]  J. Thomson,et al.  Isolation of a primate embryonic stem cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Ramshaw,et al.  Engraftment of bone marrow cells into normal unprepared hosts: effects of 5-fluorouracil and cell cycle status , 1995 .

[38]  P. Quesenberry,et al.  Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. , 1995, Experimental hematology.

[39]  H U Weier,et al.  Generation of five high-complexity painting probe libraries from flow-sorted mouse chromosomes. , 1994, Genomics.

[40]  J. Ferrara,et al.  Cytokine dysregulation as a mechanism of graft versus host disease. , 1993, Current opinion in immunology.

[41]  P. Quesenberry,et al.  Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. , 1993, Blood.

[42]  B. Zehnbauer,et al.  Fluorescence in situ hybridization to determine engraftment status after murine bone marrow transplant. , 1992, Cancer genetics and cytogenetics.

[43]  G. Jiménez,et al.  Activation of the beta-globin locus control region precedes commitment to the erythroid lineage. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. McKay,et al.  An embryonic origin for medulloblastoma. , 1991, The New biologist.

[45]  C. Parish,et al.  New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. , 1990, Journal of immunological methods.

[46]  K. Sullivan,et al.  Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. , 1989, The New England journal of medicine.

[47]  I. Bertoncello,et al.  Multiparameter analysis of transplantable hemopoietic stem cells: I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence. , 1985, Experimental hematology.

[48]  P. Quesenberry,et al.  Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential. , 1984, Journal of immunology.

[49]  M. Pollard.  HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA? , 1984, The Lancet.

[50]  R. Gale,et al.  HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA? , 1984, The Lancet.

[51]  E. Palmer,et al.  Y-encoded, species-specific DNA in mice: Evidence that the Y chromosome exists in two polymorphic forms in inbred strains , 1984, Cell.

[52]  J. Visser,et al.  Analysis and separation of murine bone marrow stem cells by H33342 fluorescence-activated cell sorting. , 1983, Experimental hematology.

[53]  K. Arai,et al.  Structure of the chromosomal gene for murine interleukin 3. , 1985, Proceedings of the National Academy of Sciences of the United States of America.